News

A liquid biopsy that measures DNA methylation has predicted early disease progression and potential survival in breast cancer patients.

Scientists from Japan identify CD69, a glycoprotein present on specific immune cells, as a new target for cancer immunotherapy.

Researchers have found that pairing a ketogenic diet with common drugs called corticosteroids prevented cachexia in mice with cancer.

Guidelines recommend germline genetic testing for people with cancers including breast, ovarian, pancreatic, colorectal, prostate and others.

Researchers demonstrate that overexpression of a gene can lead to the conversion of androgen-sensitive prostate cancer cells into castration-resistant cells, both in lab models and live samples.

A small study has identified that the fat content of a meal may affect the bioavailability of an oral cancer drug.

Researchers have investigated the mechanism of action and therapeutic potential of a new-generation acylfulvene compound in both in vitro and in vivo non-Hodgkin’s lymphoma models.

In a recently published manuscript, researchers identified a potential breakthrough in glioblastoma treatment - a novel viral therapy and a drug that activates the immune system.

By silencing the molecular pathway that prevents macrophages from attacking our own cells, scientists have manipulated these white blood cells to eliminate solid tumors.

By closely investigating some of the immune cells generated during immunotherapy, known as CD4 T cells, scientists discovered that these cells are capable of remotely neutralizing tumor cells by producing interferon gamma.